Global Decentralized & POC Coagulation Testing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Decentralized & POC Coagulation Testing Market Research Report 2024
Cardiovascular diseases present a wide range of blood disorders (haemostasis) that influences the development cardiovascular co morbidities. Patients exhibiting such symptoms are often prescribed on anti-thrombotic medications to prevent the onset of adverse cardiovascular events arising as a result of the sudden rise in blood coagulation factors. In addition, patients undergoing cardiovascular surgery also present haemostatic disorders along with their existing disease state besides their adjunctive medication or the presence of any coagulation disturbances induced by a cardiopulmonary bypass surgery. POC (Point of care) coagulation testing monitors are available for monitoring preoperative coagulation especially in procedures involving cardiovascular surgeries such as cardiac bypass, angioplasty, etc.
According to MRAResearch’s new survey, global Decentralized & POC Coagulation Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Decentralized & POC Coagulation Testing market research.
The global market for POC (Point of care) coagulation testing monitors has been, according to some estimates, growing at a slower rate in comparison to last few years due to the global recession and economic turn of markets especially of the North American and European region. The market is nevertheless expected to regain growth by the end of the forecast period with increased demand and supply from the Asian markets of China, Japan, Korea, Thailand and India.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Decentralized & POC Coagulation Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Roche Diagnostics
Abbott Laboratories
Biosite Diagnostic
Medtronic
Trinity Biotech
Polartechnics
Segment by Type
Anti-Coagulated Plasma Technology
Whole Blood Specimen Testing Kits
Satellite Anticoagulation Therapy
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Decentralized & POC Coagulation Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Decentralized & POC Coagulation Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Decentralized & POC Coagulation Testing market research.
The global market for POC (Point of care) coagulation testing monitors has been, according to some estimates, growing at a slower rate in comparison to last few years due to the global recession and economic turn of markets especially of the North American and European region. The market is nevertheless expected to regain growth by the end of the forecast period with increased demand and supply from the Asian markets of China, Japan, Korea, Thailand and India.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Decentralized & POC Coagulation Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche Diagnostics
Abbott Laboratories
Biosite Diagnostic
Medtronic
Trinity Biotech
Polartechnics
Segment by Type
Anti-Coagulated Plasma Technology
Whole Blood Specimen Testing Kits
Satellite Anticoagulation Therapy
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Decentralized & POC Coagulation Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices